Rosemary Extract Inhibits Renal Amyloidosis via ER Stress and Apoptosis Modulation

Study Background and Research Question

Renal amyloidosis (RA) is a progressive and often fatal disorder characterized by the deposition of insoluble amyloid fibrils in kidney tissues. The subsequent disruption of renal function frequently leads to nephrotic syndrome and, ultimately, end-stage renal disease. Despite its clinical significance, the molecular mechanisms underlying amyloid formation and tissue injury in RA remain incompletely understood, and effective disease-modifying therapies are lacking. Rosemary (Rosmarinus officinalis L.), a dietary herb with reported antioxidant and anti-inflammatory properties, has emerged as a candidate for renal protection. However, its impact on amyloid-driven renal pathology and the mechanistic basis for its effects have not been rigorously defined. The recent study by Li et al. (DOI: 10.1093/fqsafe/fyaf055) addresses these knowledge gaps by investigating whether rosemary ethanol extract (REE) can modulate amyloidogenesis, ER stress, and apoptosis in robust cellular and animal models of RA.

Key Innovation from the Reference Study

The central innovation of the referenced work lies in its multidimensional mechanistic exploration of rosemary extract’s anti-amyloidosis effects. Rather than focusing solely on phenotypic endpoints or a single molecular target, the study systematically examines multiple layers of amyloid pathology—from protein aggregation propensity, to subcellular calcium homeostasis, to the activation of stress and apoptotic signaling pathways. This approach enables a comprehensive understanding of how REE may confer renal protection, specifically highlighting its dual capacity to disrupt amyloid fibril formation and attenuate downstream cell death cascades. The integration of both in vitro (MES13 glomerular cell line) and in vivo (C57BL/6 mouse) models further strengthens the translational relevance of the findings.

Methods and Experimental Design Insights

To recapitulate the pathological environment of renal amyloidosis, the authors employed a lysozyme amyloid-like fibril (M-LYSO) model, which was either added to MES13 cell cultures or administered intravenously to mice. This model system facilitates the study of amyloid-induced cytotoxicity and tissue remodeling. Spectroscopic techniques were used to characterize amyloid fibril structure and monitor the impact of REE on aggregation propensity. Cellular assays assessed mitochondrial function, calcium flux, and reactive oxygen species (ROS) generation. Molecular analyses quantified the activity of the PERK/ATF-4/CHOP endoplasmic reticulum (ER) stress axis and evaluated the expression of apoptosis-related proteins. Histological examination of renal tissues provided a direct assessment of pathological changes and the extent of tissue preservation following REE administration.

Protocol Parameters

• REE administration in vivo: 100 or 200 mg/kg, delivered orally for 8 weeks to C57BL/6 mice with experimentally induced amyloidosis (see study).
• Amyloid induction: Intravenous injection of M-LYSO fibrils to mimic amyloid deposition in renal tissue.
• In vitro cell treatment: MES13 cells exposed to amyloid fibrils ± REE to assess cytoprotective effects.
• Apoptosis assessment: Detection of DNA fragmentation and apoptotic markers in kidney sections and cultured cells (see below for methodological context).
• ER stress and oxidative stress measurement: Quantification of ROS and activation of PERK/ATF-4/CHOP pathway components.

Core Findings and Why They Matter

The study's findings demonstrate that REE robustly disrupts amyloid fibril structure and reduces the aggregation of amyloidogenic proteins in both cell and animal models. In MES13 cells, REE treatment restored intracellular calcium balance, reduced ROS accumulation, and suppressed the activation of the PERK/ATF-4/CHOP ER stress pathway. Importantly, these molecular changes translated into a significant reduction in apoptosis, as evidenced by decreased DNA fragmentation and improved cell viability. Histological analyses revealed that continuous oral REE administration markedly attenuated amyloid-induced renal damage and preserved kidney function in vivo. These results suggest that rosemary extract acts at multiple mechanistic nodes—directly destabilizing amyloid aggregates and indirectly mitigating cellular stress and apoptosis—that collectively interrupt the pathogenesis of renal amyloidosis (Li et al., 2025).

Given that apoptosis is a hallmark of tissue degeneration in amyloidosis, the capacity to quantitatively monitor DNA fragmentation is critical for validating therapeutic efficacy in preclinical research. The referenced study underscores the value of apoptosis assays in both tissue sections and cultured cells for mechanistic and translational insights.

Comparison with Existing Internal Articles

Several internal resources detail the methodological and practical aspects of apoptosis detection, particularly via DNA fragmentation assays. The "Solving Lab Challenges with TUNEL Apoptosis Detection Kit" and the "TUNEL Apoptosis Detection Kit (DAB): Precision DNA Fragmentation Detection" articles both provide actionable guidance on the application of TUNEL assays for apoptosis detection in tissue sections and cultured cells. These resources align with the reference study’s workflow, wherein the detection of DNA fragmentation is a central endpoint for evaluating programmed cell death in disease models. The internal articles emphasize reproducibility, sensitivity, and versatility of TUNEL-based approaches, which are essential for dissecting apoptosis mechanisms in complex disease settings such as renal amyloidosis.

Furthermore, the "Translational Precision in Programmed Cell Death" article discusses the broader rationale for incorporating TUNEL technology in mechanistic and translational research, paralleling the reference study’s multidimensional design. Together, these internal articles and the referenced paper reinforce the importance of robust, standardized apoptosis assays for advancing disease mechanism studies and therapeutic validation.

Limitations and Transferability

While the study offers compelling evidence for the anti-amyloidosis potential of rosemary extract, several limitations warrant consideration. The amyloid model, based on lysozyme fibril injection, recapitulates key features of amyloid pathology but may not fully represent the heterogeneity and chronicity of human renal amyloidosis. Additionally, mechanistic findings in mice and cell lines may not directly extrapolate to human disease due to species-specific differences in amyloidogenic proteins and renal physiology. The precise bioactive compounds within the rosemary extract responsible for the observed effects remain to be fully characterized. Despite these constraints, the study’s integrated approach—combining molecular, cellular, and histological endpoints—enhances its relevance for future translational and preclinical investigations.

Research Support Resources

Researchers seeking to replicate or extend the methodologies described in the reference study may benefit from standardized tools for apoptosis detection. The TUNEL Apoptosis Detection Kit (DAB) (SKU K2271) from APExBIO enables sensitive and specific detection of DNA fragmentation in both tissue sections and cultured cells, supporting workflows similar to those employed by Li et al.. For further guidance on optimizing DNA fragmentation detection in programmed cell death research, related internal articles provide protocol benchmarks and troubleshooting insights. As always, careful protocol optimization and appropriate controls are essential for reliable apoptosis quantification in complex disease models.